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1. Introduction 
In anxiety disorders such as PTSD, normal fear responding and learning, which is adaptive 
and helps us survive, is altered in such way that fear becomes maladaptive, interfering with 
an organism’s ability to alter and adapt behavior in situationally appropriate ways.  
Maladaptive fear learning is thought to underlie the behavioral symptoms of anxiety 
disorders such as PTSD (Charney, 2004; Rosen & Schulkin, 1998) when fear and fear 
responses dominate behavior even in benign circumstances.  The fear learning circuit 
normally participates in adaptive learning and response to danger, however after trauma 
some individuals show symptoms of PTSD such as: abnormal response to milder stressors, 
increased vigilance and startle response (American Psychiatric Association., 2000).  Stress 
enhanced fear learning (SEFL) models some specific aspects of PTSD.  Using this model we 
can examine the consequences of trauma--how acute stress or a traumatic event 
permanently alters the way fear is learned and how these permanent changes in the fear 
learning circuitry produce maladaptive responses and maladaptive fear learning. 
Post-traumatic stress disorder (PTSD) is an anxiety disorder that is debilitating and 
profoundly affects the lives of men and women worldwide.  The Diagnostic and Statistical 
Manual of Mental Disorders (DSM) criterion for a diagnosis of PTSD requires exposure or 
experience of a traumatic or life-threatening event (American Psychiatric Association., 2000).  
Trauma may be caused by combat, violence (such as assault, rape, robbery), severe 
accidents, disasters (natural or man-made).  Any one of these traumatic events will be 
experienced by one-third of the population (Brunello et al., 2001).  While the majority of 
people will not develop PTSD, it is estimated that 10 to 20% of people who experience an 
acute traumatic event will develop the disorder (Brunello et al., 2001).  Symptoms of PTSD 
include re-experiencing of the trauma, avoidance, and hyper-arousal.  Re-experiencing of 
the trauma can manifest as vivid and emotionally intense memories of the event in 
flashbacks, nightmares, or ruminations that give the patient a feeling of re-living the trauma.  
Avoidance of situations, people, or places that remind patients of the trauma is another 
aspect of the disorder.  Increased physiological and psychological arousal, including 
enhanced startle response and hyper-vigilance also contribute and are indicative of the 
maladaptive fear learning associated with PTSD. 
PTSD is thought to be much more prevalent than the estimated 7.8%.  Furthermore, many 
cases of PTSD may be unreported and thus undiagnosed (Brunello et al., 2001). 
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Compounding the difficulty of diagnosis, PTSD is frequently co-morbid with other anxiety 
disorders, major depression and substance abuse (Goisman et al., 1998; Kessler, Sonnega, 
Bromet, Hughes, & Nelson, 1995), making therapeutic treatment a challenge and in some 
patients ineffective (Brunello et al., 2001).    
Some types of therapy used to treat PTSD include cognitive behavioral therapy (CBT), 
exposure therapy, systematic desensitization, psychotherapy, and pharmacological 
therapies. Treatments such as CBT, which include exposure therapy, are a primary 
treatment for anxiety disorders including PTSD and these therapies can be effective 
treatments for some features of PTSD, for reviews see (Olatunji, Cisler, & Deacon, 2010; 
Roberts, Kitchiner, Kenardy, & Bisson, 2010).  However, behavioral (exposure) therapy is 
not entirely effective in eliminating symptoms such as exaggerated responses to milder 
reminder stimuli (Craske et al., 2008).   
Pharmacological treatments for PTSD are also common.  Anti-depressant drugs such as 
selective serotonin reuptake inhibitors (SSRIs) are among the drugs that are frequently 
prescribed in the initial treatment of PTSD symptoms (Berger et al., 2009). Often medications 
that have been developed for use in other psychological disorders (depression, anxiety, anti-
hypertensives, anti-psychotics) are used to treat PTSD (Hamner, Robert, & Frueh, 2004); 
however, because the mechanisms of PTSD are not clearly understood pharmacological 
treatments have also been only partially efficacious.  Thus, marginal improvements in PTSD 
symptoms produced by treatments such as CBT and pharmacotherapy may be because they 
are not addressing some of the underlying neurobiological changes that lead to some of the 
maladaptive symptoms of PTSD.  
Animal models of PTSD can capture some of the behavioral and neurobiological symptoms 
of the disorder and are useful as tools to examine specific aspects of maladaptive fear 
learning that cannot be studied in humans.  These models use various methods for 
simulating a traumatic event; exposure to predator scent, restraint, and Pavlovian fear 
conditioning that uses tone—foot-shock pairings are among the most common methods.  
Stress enhanced fear learning (SEFL), however, is an animal model of PTSD that uses un-
signaled, unpredictable foot-shock to mimic and induce trauma; using SEFL we examine 
how new fear learning after trauma is sensitized.  The hallmark of SEFL is an exaggerated 
fear learning to a mildly aversive stimulus (Rau, DeCola, & Fanselow, 2005); the animal 
learns to fear contextual cues formed in an environment that is distinct and distinguishable 
from the environment where the trauma took place, but after receiving a single shock 
responds with exaggerated fear, as if it were in the trauma environment.  Thus, in SEFL as in 
PTSD, fear learning that is normally an adaptive process that helps the animal survive 
becomes maladaptive and disruptive to normal functioning when inappropriate fear 
responses are triggered.  Using SEFL we can examine two aspects of learning that occur as a 
result of traumatic stress: the associative component, which is fear learning that is directly 
conditioned to the contextual cues present during the trauma, and the non-associative 
component, which is more like sensitization in that new fear is acquired after trauma that is 
disproportionate and not directly related to the trauma (Ponomarev, Rau, Eger, Harris, & 
Fanselow, 2010).  In the following experiments we examine the efficacy of three compounds 
on SEFL: midazolam, propranolol, and allopregnanolone.   
In Experiment 1 we examined the effects of midazolam, a potent anxiolytic and amnestic 
agent that readily crosses the blood brain barrier and is a positive modulator at GABAA 
receptors.  Midazolam is commonly used pre-operatively in hospitals to alleviate patient 
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anxiety and induce amnesia for pre-anesthesia procedures (Bauer, Dom, Ramirez, & 
O'Flaherty, 2004).  Studies of human memory have found that midazolam induced deficits 
in declarative memory while sparing implicit memory (Stewart, Buffett-Jerrott, Finley, 
Wright, & Valois Gomez, 2006; Thomas-Anterion, Koenig, Navez, & Laurent, 1999).  In 
animals, midazolam administered prior to restraint stress reduced later conditional 
responding in an environment where the animals had received foot-shock (Rodriguez 
Manzanares, Isoardi, Carrer, & Molina, 2005).  However, others studies have found that 
midazolam altered fear memory in animals that had not experienced prior stress but in 
animals that had been exposed to prior stress midazolam did not attenuate fear memory 
(Bustos, Giachero, Maldonado, & Molina, 2010). Thus, in Experiment 1 we investigated how 
midazolam-induced amnesia for the trauma would impact subsequent fear learning—if 
memory for the traumatic event is necessary for SEFL to occur. 
Experiment 2 examined the effect of systemic administration of propranolol on SEFL.  
Propranolol is a commonly used heart medication as a treatment for tachycardia and has 
also been used to treat performance anxiety; it is often referred to as a specific b-adrenergic 
(Brantigan, Brantigan, & Joseph, 1982; Gerber, Freed, & Nies, 1980) antagonist (although it 
should be noted that propranolol also influences 5-HT receptors by inhibiting re-uptake of 
serotonin).  Propranolol has more recently been examined as a possible treatment for PTSD 
(Vaiva et al., 2003). Increased responsiveness of the noradrenergic system in patients with 
PTSD is thought to underlie some symptoms of the disorder (Southwick et al., 1999) as well 
as enhance memory formation (Cahill, Prins, Weber, & McGaugh, 1994; Liang, Juler, & 
McGaugh, 1986). b-adrenergic blockade is thought to dull emotional responsiveness and 
decrease physiological hyper-arousal (Southwick et al., 1999).  Thus, propranolol, because of 
its pharmacological action at noradrenergic receptors in both the peripheral and central 
nervous systems is an attractive treatment for symptoms of PTSD.  However, the results 
from experiments in both humans (Kindt, Soeter, & Vervliet, 2009; McGhee et al., 2009; 
Vaiva et al., 2003; van Stegeren, Everaerd, & Gooren, 2002) and animals (Cahill, Pham, & 
Setlow, 2000; Muravieva & Alberini, 2010) have been inconsistent.  In Experiment 2 we 
wanted first to determine if peri-trauma (administration of the drug both before and after 
trauma) injections of propranolol would mitigate SEFL, and second to determine if 
propranolol had an effect upon the memory for the trauma. 
In Experiment 3 we examined how acute administration of the neurosteroid 
allopregnanolone (3-a-hydroxy-5 a -pregnan-20-one) would affect SEFL.  Allopregnanolone 
is a powerful positive allosteric modulator of GABAA receptors containing the a4 and d 
subunits (Smith, Shen, Gong, & Zhou, 2007). Thus, allopregnanolone enhances GABAergic 
transmission, increasing inhibitory influence of the neurons resulting in anxiolysis, sedation, 
and analgesia (Belelli & Lambert, 2005).  Evidence from functional magnetic resonance 
imaging (fMRI) studies show that the amygdala, which is known to be important in fear 
learning, recognition and expression, was observed to be over-active in patients with PTSD 
(Rauch, Shin, & Phelps, 2006; Rauch et al., 2000).  GABAergic disinhibition can produce 
increases in neural excitability and plasticity that may lead to pathological anxiety (Rainnie 
et al., 2004; Shekhar, Truitt, Rainnie, & Sajdyk, 2005), and levels of allopregnanolone in 
plasma as well as in the brain are increased in response to acute stress.  These increases in 
allopregnanolone are thought to act as a regulatory mechanism that restores balance 
between excitatory and inhibitory neurotransmission after stress (Barbaccia, Concas, Serra, 
& Biggio, 1998; Purdy, Morrow, Moore, & Paul, 1991).  In patients with PTSD, decreased 
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levels of allopregnanolone in cerebrospinal fluid have been observed and severity of 
symptoms was correlated with low levels of allopregnanolone (Rasmusson et al., 2006).  In 
mice that experienced social isolation stress and enhanced contextual fear conditioning, 
structures involved in fear learning (hippocampus, amygdala, and frontal cortex) showed 
decreased levels of in allopregnanolone (Pibiri, Nelson, Guidotti, Costa, & Pinna, 2008).  
Systemic injections of either allopregnanolone or S-norfluoxetine mitigated the enhanced 
contextual conditioning, presumably by exerting their effects at GABAA receptors 
containing the a4, a6 and d subunits where neurosteroids have high affinity (Pibiri et al., 
2008; Pinna, 2010).  Changes in gene expression in the SEFL phenotype reveal down-
regulation of several GABAA receptor subunits, among the down-regulated receptor subunit 
types are the a4 subunits (Ponomarev et al., 2010).  Therefore, we boosted circulating levels 
of allopregnanolone during traumatic stress or during the single shock trial in order to 
examine if allopregnanolone could mitigate trauma induced over-activation in the brain by 
enhancing GABAergic transmission globally, thus decreasing SEFL.  
2. Method 
2.1 Subjects 
In the following experiments subjects were experimentally naïve adult male Long-Evans 
rats purchased from Harlan (Indianapolis, IN).  At the beginning of the experiment rats 
were 90 days old and weighed 340-370g.  Rats were housed individually on a 12-hour 
light/dark cycle with free access to food and water.  Animals were initially handled 1-2 
minutes per day for a week prior to the start of Experiment 1.  Procedures used in these 
experiments were conducted in accordance with the Division of Laboratory Animal 
Medicine and approved by the Animal Research Committee at the University of California, 
Los Angeles.  For Experiments 1 and 2, 32 rats were used for each experiment; in 
Experiment 3, 40 rats were used. 
2.2 Apparatus 
2.2.1 Experiment 1 
Procedures took place in two distinct training/testing environments, Context A, the trauma 
environment and Context B, the novel environment.  Each context contained distinguishable 
background noise, lighting, and odor in fear conditioning boxes that differed in interior 
size/shape, texture and grid floor pattern designed to minimize generalization between the 
contexts.  Context A chambers (28x21x22 cm; Lafayette Instruments, Lafayette, IN) were 
aluminum sided with an opaque Plexiglas back and clear Plexiglas front door piece.   Grid 
floors (18 stainless steel rods, 4 mm diameter, 1.5 cm apart) were connected to a shock 
generator and scrambler (Lafayette Instrument Co.; Lafayette, IN).  Overhead fluorescent 
lighting and a ventilation fan provided 70 dB of background noise.  Fear conditioning boxes 
were cleaned and dried between each session using a 10% sodium hydroxide solution.  
Stainless steel pans were placed beneath each grid floor in the chambers, these contained 4-5 
sprays of atomized Simple Green as the context odor.  Metal scaffolding attached to a cart 
was used to transport the animals in their home cages to Context A and back.   
The interior of the Context B chambers, initially the same as described above, were modified 
by inserting white Plexiglas along the rear wall and two white Plexiglas side-walls at 60º 
angles that formed an A-frame.  As in Context A, the front door piece consisted of a clear 
Plexiglas panel.  The grid floor, connected to a shock generator and scrambler (Lafayette 
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Instrument Co.; Lafayette, IN), consisted of 17 stainless steel rods (4 mm diameter) spaced in 
offset rows 1 cm vertically and 2.6 cm horizontally.  Lighting consisted of one red 30-watt 
incandescent bulb.  A white noise generator produced background noise (70 dB, A-scale).  
Fear conditioning chambers were cleaned, using a 1% acetic acid solution, and dried 
between each session. Stainless steel pans were placed beneath each grid floor in the 
chambers; these contained 4-5 sprays of an atomized 11% coconut extract mixture as the 
context odor.  Animals were transported to and from their home cages in a covered, black 
rubberized box subdivided into four areas by black Plexiglas panels. 
2.2.2 Experiments 2 and 3 
Behavioral testing took place in fear conditioning chambers (30x25x25 cm, Med-Associates 
Inc., St. Albans, VT), which were equipped with a Med-Associates VideoFreeze system and 
sound attenuating chambers.  The SEFL 15-shock trauma procedure was conducted in a set 
of four conditioning chambers (Trauma context); the single shock and SEFL memory test 
were conducted in a separate set of four conditioning chambers (Novel context).  The two 
contexts were housed in separate rooms and were perceptually distinct from one another, 
differing in interior chamber shape, room and chamber lighting, scent, cleaning solution, 
background noise, and transport to the conditioning chambers.   
The Trauma context interior was rectangular in shape with aluminum side-walls, a Plexiglas 
rear wall either with blue dots or covered with an opaque white panel, and a clear Plexiglas 
hinged front door panel.  The grid floors that deliver the electric foot-shocks consisted of 
evenly spaced standard grid rods (4.8 mm thick, Contextual Conditioning System, Med-
Associates Inc.).  Chambers received light from sources mounted above each chamber; the 
room that housed the conditioning chambers was a standard overhead fluorescent light.  
Stainless steel pans were placed beneath each grid floor in the chambers; these contained 4-5 
sprays of atomized Simple Green as the context scent. Fans mounted on each conditioning 
chamber provided background noise (60 dB).  Animals were transported in their home cages 
using a portable cart affixed with hanging racks and covered by a white sheet.  Between 
groups of animals chambers were cleaned with 70% isopropyl alcohol.     
For the Novel context, where the single shock and SEFL memory test took place, black 
plastic inserts were used to create a triangular shape (60º angles that formed an A-frame) 
within the conditioning chamber.  The rear of the chamber was covered with an opaque 
white panel, and the front, hinged door was clear Plexiglas.  The grid floors consisted of 
vertically and horizontally off set rods (4.8 mm thick, Contextual Conditioning System, 
Med-Associates Inc.).  The black plastic inserts obscured the top lighting within the 
conditioning chambers, and the room lighting consisted of one red 30-watt incandescent 
bulb. Stainless steel scent pans contained 4-5 sprays of atomized 1% acetic acid solution as 
the context scent.  The background fan in these chambers was turned off (<50 dB).  Animals 
were transported to and from their home cages in a covered, black rubberized box 
subdivided into four areas by black Plexiglas panels partially filled with rodent bedding; the 
subdivided box was transported atop a small rolling cart.  Between groups the chambers 
were cleaned with 1% acetic acid solution.  All chambers were cleaned with a 10% bleach 
solution at the end of each day of testing. 
2.3 SEFL procedure and extinction 
Animals were placed into fear conditioning chambers where they received 15 (1 mA, 1 sec) 
foot-shocks; control animals received equivalent context exposure but without foot-shock. 
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The foot-shocks were un-signaled, inescapable and occurred at pseudo random intervals 
temporally spaced from three to eight minutes apart for a period of 90 minutes.  Twenty-four 
hours later, animals were placed into a novel context. As described above odor, lighting, 
spatial location, enclosure shape, flooring, and background noise were unique to context (set 
of four conditioning chambers). In the Novel Context, baseline activity levels and fear were 
assessed for the first three minutes.  Following the initial three minutes the animals were given 
a single (1 mA, 1 sec) foot-shock and level of fear was measured for five minutes. Animals 
were then returned to their home-cages. The test of SEFL occurred 24 hours later when the rats 
were returned to the context where they received the single shock; the animals were then 
given an eight-minute test of contextual fear learning. Control animals received the same 
amount of exposure to the trauma environment but did not receive foot-shocks. On 
subsequent days, the control animals received the same treatment as the SEFL group, a single 
shock in the novel environment and a test of fear to that second environment. 
In Experiment 1, extinction took place in the 15-shock trauma context.  Animals were placed 
into the conditioning chambers for five 30-minute context extinction sessions spaced 5-
minutes apart.  Exctinction procedures occurred on the day following the 15-shock SEFL 
procedure and 24 hours before the single shock in the Novel Context. 
2.4 Systemic injections 
Animals were habituated to positioning and handling associated with i.p. injections for 2-3 
days prior to the beginning of each experiment.   
2.4.1 Experiment 1 
On the drug injection day midazolam animals were injected using 29-gauge 0.5 cc sterile 
insulin syringes. Animals received injections of either 2 mg/kg of midazolam hydrochloride 
(Hospira, Inc., Lake Forest, IL, USA) at a concentration of 5 mg/mL or the equivalent 
amount of sterile saline (0.9%).  Injections occurred 20 minutes prior to the start of the 15-
shock SEFL procedure. 
2.4.2 Experiment 2 
Animals were injected with either DL-propranolol (Sigma-Aldrich, St. Louis, Mo., USA), 
dissolved in phosphate buffered saline (PBS) for a final concentration of 5mg/ml, or PBS 
with 26-gauge sterile syringes.  Animals were given injections (5 mg/kg) both 20 minutes 
prior to the 15-shock SEFL conditioning and within 20 minutes following the SEFL 
procedure; thus, animals received either a total of 10 mg/kg of propranolol or equivalent 
volumes of PBS over two injections.  At this dosage, studies have found that locomotor and 
exploratory activity was unaffected, but did reduced the effects of predator stress on 
behavioral measures of anxiety such as social interaction, hole board, light/dark box, 
elevated plus maze, and after re-activation of memory in an inhibitory avoidance procedure 
(Adamec, Muir, Grimes, & Pearcey, 2007; Przybyslawski, Roullet, & Sara, 1999). 
2.4.3 Experiment 3 
Animals were given i.p. injections (26-gauge sterile syringes) of either allopregnanolone 
(ALLO, Sigma-Aldrich, St. Louis,  
Mo., USA) suspended in a 22% solution of (2-hydroxypropyl)-b-cyclodextrin solution (CDX) 
in sterile saline (0.9%) for a final concentration of 3 mg/ml, a 22% solution of CDX in sterile 
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saline (0.9%), or injections of sterile saline (0.9%).  Animals were given injections 20 minutes 
prior to the 15-shock SEFL conditioning; 5 mg/kg of ALLO and equivalent volumes of CDX 
solution or Saline.  Using this dose of ALLO studies found behavioral effects on alcohol 
consumption after injections but no adverse side effects in rats (Janak & Gill, 2003; Janak, 
Redfern, & Samson, 1998) and in mice doses of 5-10 mg/kg or greater are used (Pibiri et al., 
2008). 
2.5 Designs and analysis 
2.5.1 Experiment 1: Midazolam 
Animals were randomly assigned to one of three groups: midazolam pre-trauma 
(MDZ/Trauma), n = 12; saline pre-trauma (SAL/Trauma), n = 12; or saline no-trauma 
(SAL/No Trauma), n = 12.  On day 1 all animals received systemic (i.p.) injections of either 
midazolam or saline followed 20 minutes later by the 15-shock SEFL procedure.  Twenty-
four hours later, on day 2 all animals were extinguished in the trauma context (Context A) 
using a massed extinction procedure.  On day 3 animals received the single shock in the 
Novel context and were tested for new fear memory in that context 24 hours later (day 4).  
Fear memory for the 15-shock trauma context was measured on day 5.  For the trauma 
context fear memory test 2 animals per group were not used due to an experimenter error 
yielding the following group sizes: midazolam pre-trauma (MDZ/Trauma), n = 10; saline 
pre-trauma (SAL/Trauma), n = 10; or saline no-trauma (SAL/No Trauma), n = 10. 
Data Analysis 
Freezing scores were used as a measure of learned fear (Fanselow, 1980), and were 
determined by averaging over behavioral observations (recorded on video tape) made every 
8 s  during each test (percentages were calculated by dividing number of observations of 
freezing by the total number of observations multiplied by 100).  Freezing is defined as the 
lack of movement except for respiration (Fanselow, 1980).  Freezing scores were calculated 
for baseline freezing in Context B prior to the single shock, post-shock freezing in context B, 
freezing conditioned by the single shock in Context B, and freezing in the original trauma 
context (A).  Conditioning and testing were videotaped and a trained, blind observer scored 
and calculated freezing scores.   
Freezing scores were calculated as described above and group differences were analyzed 
using a one-way analysis of variance (ANOVA) for each designated time period.  Statistical 
significance was determined at p < 0.05.  Post-hoc multiple comparisons among groups 
were made using Tukey HSD tests in order to specify group differences within each 
measurement period. 
2.5.2 Experiment 2: Propranolol 
Animals were randomly assigned to one of four groups in a 2x2 factorial design.  Animals 
were designated by prior experience as having either received either No Prior Trauma or 
Trauma, and by drug treatment either injected with propranolol or vehicle.  Thus the four 
groups consisted of: No Prior Trauma/Vehicle, n = 8; No Prior Trauma/Propranolol, n =8 ; 
Trauma/Vehicle, n = 8; Trauma/Propranolol, n = 8.  On day 1 of the experiment all animals 
were injected systemically (i.p.) with either propranolol or Vehicle  20 minutes before the 
start of the 15-shock SEFL procedure.  Following the SEFL procedure animals were re-
injected with propranolol or vehicle.  Twenty-four hours later, on day 2, all animals were 
placed in the Novel context where they received a single foot-shock.  On day 3 animals were 
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tested for SEFL during a fear memory test in the Novel context.  Animals were placed again 
in the trauma context, where they had received the 15 shocks and were tested for fear 
memory on day 4. 
Data Analysis 
Freezing scores were used as a measure of learned fear (Fanselow, 1980; Fanselow & Kim, 
1994).  Freezing behavior was scored using VideoFreeze software (Med-Associates Inc.).  
During behavioral testing, digital video information from cameras mounted in conditioning 
chambers was recorded in near-infrared light (NIR).  An analysis algorithm that compared 
pixels of a sample reference frame against real-time continuous frame samples was summed 
to produce the Motion Index.  Activity below a Motion Index of 50 units for duration of 30 
frames (or more) per second was scored as freezing.  In a validation study, freezing scores 
generated by the VideoFreeze software and freezing scores generated by human scoring 
were highly correlated, r = 0.971, p < 0.0001 (Anagnostaras et al., 2010); a high correlation 
between the VideoFreeze scoring and two highly trained observers (r > 0.9) has also been 
reported by this laboratory (Jacobs, Cushman, & Fanselow, 2010). Average freezing scores 
were calculated for baseline freezing in the novel context for 3 minutes prior to the single 
shock; post-shock freezing in the novel context was assessed for 5 minutes.  The SEFL test in 
the novel context and the trauma context fear memory test measured freezing for 8 minutes. 
Freezing scores were calculated as described above and group differences were analyzed 
using a two-way analysis of variance (ANOVA) for each designated time period.  Statistical 
significance was determined at p < 0.05.  
2.5.3 Experiment 3: Allopregnanolone 
Animals were randomly assigned to one of five groups.  All animals experienced the same 
behavioral procedures: 15-shock trauma, a single shock in the Novel Context, the SEFL test 
in the Novel Context, and a fear memory test in the Trauma Context.  Animals received 
either ALLO, saline, or CDX vehicle prior to the 15-shock trauma, or ALLO or saline prior to 
the single shock in the Novel Context.  The five groups were as follows: ALLO Pre-trauma, 
n = 10; SAL Pre-trauma, n = 10; CDX Pre-trauma, n = 8; ALLO Pre-1shk, n = 6; SAL Pre-
1shk, n = 6.  
Data Analysis 
Data analysis was similar to data analysis described for Experiment 2, however for 
Experiment 3 a one-way ANOVA was used to determine statistical significance among 
groups. 
3. Results 
3.1 Experiment 1: Midazolam alters fear memory for trauma but does not alter SEFL 
Novel Context baseline fear 
As Figure 1 illustrates all three groups showed very low levels of fear to the Novel context 
during the 3 minute period before the onset of the single shock.  There were no statistically 
significant differences among the groups, F (2, 33) = 1.38, p = 0.27.  Lack of group differences 
in baseline fear indicates whatever fear was acquired during the trauma experience did not 
generalize to the Novel context. 
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Novel Context post-single shock fear 
Fear in the Novel context during the 5 minute period following the single shock was low in 
the SAL/No Trauma animals while post-shock freezing for both the SAL/Trauma and 
MDZ/Trauma groups was high.  Figure 1 illustrates these group differences.  A one-way 
ANOVA confirmed these group differences, F (2, 33) = 11.98, p < 0.001, and post-hoc 
comparisons revealed significant differences between the SAL/No Trauma group (M = 
14.17, SD = 14.67) and both prior trauma groups, however there was no reliable difference 
between SAL/Trauma animals (M = 63.54, SD = 35.82) and MDZ/Trauma animals (M = 
43.26, SD = 32.99). 
Novel Context: SEFL memory test 
Fear memory for the Novel Context was measured to assess the amount of context specific 
fear was acquired by the single shock on the previous day.  The measure of freezing during 
the 8 min 32 s test serves as the primary indicator of stress enhanced fear learning.  Figure 2 
demonstrates this effect; animals that received no prior trauma show a small amount of new 
fear to the single shock context while animals that received the prior 15-shock trauma 
display a disproportionately high amount of new fear, that is enhanced fear learning, was 
unmitigated by experiencing trauma under the drug midazolam.  These observations were 
bourn out by a one-way ANOVA, F (2, 33) = 6.33, p < 0.01.  Post-hoc analyses confirmed that 
the SAL/No trauma group (M = 9.25, SD = 11.26) differed from both the SAL/Trauma (M = 
38.93, SD = 24.72) and the MDZ/Trauma groups (M = 36.33, SD = 28.28).  There was no 
reliable difference in freezing between the SAL/Trauma and MDZ/Trauma groups. 
 
 
Fig. 1. Experiment 1 Systemic midazolam: Novel Context baseline and post-single shock fear. 
Mean percent time freezing (+/- SEM) in the Novel context before and after the single 
shock. All groups showed very low freezing during the baseline measurement period 
preceding the single shock.  Following the single shock animals that did not have prior 
trauma showed little fear after the single shock, whereas both the saline and midazolam 
groups that had prior trauma showed high levels of fear following the single shock.  
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Fig. 2. Experiment 1 Systemic midazolam: Novel Context SEFL memory test.  
Mean percent time freezing (+/- SEM) in the novel context 24-hours after the single shock.  
The saline injected group without prior trauma showed low to moderate levels of fear in the 
Novel context.  The saline and midazolam injected groups that had prior trauma showed 
equivalent levels of enhanced fear, indicating that midazolam did not attenuate SEFL. 
Trauma Context memory test 
Fear memory for the Trauma context was assessed during an 8 min 32 s period on the day 
following the SEFL test in the Novel Context.  As shown in Figure 3 animals that did not 
receive the prior trauma in this context showed low levels of freezing; animals that received 
saline injections before the 15-shock trauma displayed comparatively high levels of freezing, 
while animals that received midazolam before the 15-shock trauma showed a decrease in 
fear to the trauma context.  A one-way ANOVA revealed reliable differences among the 
groups, F (2, 27) = 3.70 p < 0.05.  Post-hoc analyses confirmed differences between the 
SAL/No Trauma group (M = 8.13, SD = 8.52) and the SAL/Trauma group (M = 32.03, SD = 
19.66), but no reliable difference from the MDZ/Trauma group (M = 25.31, SD = 27.81).  The 
lack of reliable difference between the MDZ/Trauma group and the SAL/No Trauma group 
suggests that midazolam altered memory for the traumatic experience; however, the 
MDZ/Trauma group was also not reliably different from the SAL/Trauma group, 
suggesting partial amnesia for the trauma.  
The findings from Experiment 1 suggest that SEFL is unchanged by manipulations that alter 
the fear memory for the trauma; neither partial amnesia produced by midazolam in 
conjunction with massed extinction, nor massed extinction alone were able to diminish 
SEFL.  This is consistent with the findings of Rau et al. (2005) in which neither spaced 
extinction nor disruption of context fear learning were able to abolish SEFL; spaced 
extinction over five days, and intra-ventricular administration of the N-methyl-D-aspartate 
(NMDA) receptor antagonist DL-2-amino-5-phosphonovalerate (APV) effectively eliminated 
fear in the trauma context, yet SEFL still occurred.  Thus, even while the associative  
 
www.intechopen.com
Pharmacological Resistance of Stress Enhanced Fear  
Learning in an Animal Model of Post-Traumatic Stress Disorder 249 
 
 
Fig. 3. Experiment 1 Systemic midazolam: Trauma Context memory test.  
Mean percent time freezing (+/- SEM) in the Trauma context.  Saline injected animals that 
did not have prior trauma displayed little fear for the trauma context while saline injected 
animals that did receive the 15-shock trauma displayed fear even after extinction of fear in 
this context.  Midazolam injected animals showed some fear memory for the trauma context, 
however, compared to saline/trauma counterparts fear memory was diminished. 
component of SEFL, the fear directly related to the trauma, can be altered and diminished by 
various methods, the non-associative sensitization of fear learning remains unaffected.  
Because both extinction and manipulations of memory for the trauma are exerting their 
effects upon the associative aspects of trauma-related fear, in Experiment 2 we used 
propranolol, which has been found to reduce memory enhancements for emotionally 
arousing material (Cahill, Babinsky, Markowitsch, & McGaugh, 1995) and has been studied 
as a possible treatment of PTSD (Vaiva et al., 2003). 
3.2 Experiment 2: Propranolol does not diminish SEFL or alter trauma fear memory 
Novel Context SEFL memory test 
As illustrated in Figure 4 animals that received no prior trauma under vehicle or 
propranolol showed low levels of fear when tested in the Novel environment where they 
had previously received the single shock, whereas animals that had experienced the 15-
shock trauma either with vehicle or propranolol showed high levels of fear.  These group 
differences were confirmed statistically; a two-way ANOVA revealed a main effect of prior 
experience (No prior trauma or Trauma), F (1, 28) = 40.51, p < 0.001.  There was no main 
effect of drug and no interaction.  These results indicate that propranolol had no effect on 
the acquisition of new fear in the single shock environment—SEFL was evident in animals 
that had received prior trauma whether they had received vehicle or propranolol. 
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Fig. 4. Experiment 2 Systemic propranolol: Novel Context SEFL memory test.  
Mean percent time freezing (+/- SEM) in the Novel context 24 hours after the single shock.  
Animals that had no trauma and received either vehicle or propranolol did not differ in fear 
learning to the single shock context.  Vehicle treated animals that had prior trauma showed 
the typical SEFL phenomenon.  Propranolol treated animals with prior trauma also showed 
SEFL, indicating that propranolol administration did not alter subsequent fear learning.  
Trauma Context fear memory test 
Animals displayed the same pattern of results as in the SEFL test; regardless of whether 
animals were treated with vehicle or propranolol, animals that had not received prior 
trauma showed low levels of fear when returned to the trauma context and animals that had 
experienced trauma there showed very high levels of fear.  This is depicted in Figure 5.  
Statistical analysis confirmed that there was again a main effect of prior experience (No 
prior Trauma or Trauma), F (1, 28) = 72.40, p < 0.001, but no main effect of drug and no 
interaction.  The clear absence of an effect of propranolol suggests that the drug was not 
producing behavioral changes that should be evident if the drug had altered how the 
trauma had been experienced.  
We found that propranolol, when administered systemically before and after traumatic 
stress, had no effect on SEFL, nor did it alter fear memory of the traumatic event.  Thus, 
neither the associative nor the non-associative aspects of SEFL were changed by 
propranolol.  The null results of propranolol that we observed may indeed be similar to the 
findings of McGhee et al. (2009) who found no effect of propranolol on the development of 
symptoms of PTSD in soldiers who suffered combat related burns. However, these findings 
are in contrast to Viava et al. (2003) who found that instances of PTSD were reduced when 
propranolol was given post-trauma to car accident or assault victims.  Acute stress is known 
to engage stress response centrally as well as peripherally.  One biological effect of stress in 
the brain, and a consequence of corticosterone (in rats) release, is endogenous release of the 
neurosteroid allopregnanolone.  Allopregnanolone is co-released from GABAergic neurons 
and is a positive modulator at GABAA receptors, enhancing GABAergic transmission in the 
brain. Allopregnanolone is produced and released centrally as well as peripherally, crossing 
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the blood-brain barrier readily. Thus, in Experiment 3 we examined the effect of boosting 
levels of available allopregnanolone via acute systemic injections either before the traumatic 
stress or before the single shock episode. 
 
 
Fig. 5. Experiment 2 Systemic propranolol: Trauma Context fear memory test.  
Mean percent time freezing (+/- SEM) in the 15 shock Trauma context.  Both vehicle and 
propranolol injected animals that did not have prior trauma displayed low levels of 
freezing.  Similarly, vehicle and propranolol injected animals that had prior trauma showed 
high levels of freezing, suggesting that fear memory for the trauma context was not altered 
by propranolol. 
3.3 Experiment 3: Systemic administration of allopregnanolone does not alter SEFL 
Novel Context SEFL memory test 
As illustrated in Figure 6 animals that received ALLO administration prior to the trauma or 
prior to the single shock showed no reduction in SEFL, and animals in both the saline 
injection and CDX control groups displayed characteristically high levels of fear in the 
Novel Context.  A one-way ANOVA confirmed that there were no overall group differences, 
F (4, 35) = 1.60, p = 0.196. These results suggest that the anxiolytic properties of 
allopregnanolone were not sufficient at this dose or by this route of administration to 
mitigate the fear sensitizing effects of prior trauma. 
Trauma Context fear memory test 
Figure 7 shows the same pattern of results as seen in the SEFL memory test.  ALLO did not 
attenuate associative fear learning in the Trauma Context.  As expected, SAL and CDX controls 
showed very high levels of fear when returned to the Trauma Context.  Group differences 
were not statistically significant, F (4, 35) = 1.51, p = 0.22.  Fear memory for the Trauma 
environment was not decreased by prior administration of allopregnanolone, suggesting the 
effect of systemic allopregnanolone had no detectable effects on the 15-shock trauma. 
www.intechopen.com
 
Anxiety Disorders 252 
 
Fig. 6. Experiment 3 Systemic allopregnanolone: Novel Context SEFL memory test.  
Mean percent time freezing (+/- SEM) in the Novel context 24 hours after the single shock.  
Pre-trauma injections of allopregnanolone, CDX, or saline did not reliably diminish 
exaggerated freezing in the Novel context.  In animals that received injections of either 
saline or allopregnanolone before the single shock there were also no reliable differences.   
 
 
Fig. 7. Experiment 3 Systemic allopregnanolone: Trauma Context fear memory test. 
Mean percent time freezing (+/- SEM) in the 15 shock Trauma context.  Trauma context fear 
memory was not reliably altered by pre-trauma injections of allopregnanolone, CDX, or 
saline.  Fear memory for the trauma context was not changed by subsequent administration 
of either saline or allopregnanolone. 
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Our results from Experiment 3 indicate that allopregnanolone given in an acute systemic 
does not attenuate SEFL at the dose of 5 mg/kg.  We found that systemic injections of the 
drug administered either before the traumatic event or before the single shock stressor had 
no effect on how new fear was acquired subsequent to trauma.  These findings are in 
contrast with those of Pibiri et al. (1998) and Pinna (2010) who found that systemic 
administration of allopregnanolone reduced negative consequences, such as enhanced 
contextual fear conditioning, in rats that had experienced social isolation stress.   
4. Discussion 
Our results indicate that SEFL is resistant to pharmacological manipulations that targeted 
either the GABAergic or noradrenergic neurotransmitter systems. Midazolam, though it 
appeared to alter the memory for the traumatic event, was ineffective at eliminating SEFL. 
Indeed, neither midazolam nor allopregnanolone, both of which increase GABAergic 
inhibition (achieved via potentiation of somewhat different GABAA receptor populations) 
affected SEFL.  Nor was SEFL affected by manipulation of noradrenergic transmission using 
the b-noradrenergic blocker propranolol.   
SEFL is a robust behavioral phenomenon that seems to be refractory to several of the 
pharmacological treatments used to treat anxiety and PTSD; indeed, the SEFL inducing 
trauma seems to produce behavioral symptoms akin to treatment refractory PTSD where the 
symptoms of the disorder are not mitigated by behavioral and pharmacological treatments.  
Additionally, systemic administration of drugs, while useful for clinical translation, is a 
limited tool in that we cannot specify where in the brain the drug will exert an effect.  
Indeed, global effects may reflect contradictory actions of the drug; among brain regions it is 
possible that the lack of drug effects may occur by offsetting actions on different brain 
regions.  While the three compounds that we examined in these experiments all readily 
cross the blood brain barrier, we should not overlook possible effects of the drugs in the 
periphery or overlook the role of feedback from the periphery influencing processes in the 
central nervous system.  In these experiments we used acute administrations of each drug 
on a single day of the experiment.  Although the time points for drug administration were 
chosen in order to assess specific effects upon either the trauma memory or upon single 
shock memory it is possible that multiple doses following the trauma (more similar to 
pharmaco-treatment regimes) might have produced a detectable effect. 
Limitations of midazolam 
Although midazolam, administered systemically, was likely acting upon diverse regions in 
the brain, it is believed that the effect of the drug is mainly exerted in the hippocampus 
(Frank, O'Reilly, & Curran, 2006).  The effect of midazolam on inhibition of neurons within 
the hippocampus explains midazolam’s amnestic quality, GABAergic transmission there 
would be increased, potentially deterring the formation of declarative memory.  Rau et al. 
(2005) has previously shown that amnesia for the trauma could be induced using intra-
ventricular infusions of APV to block NMDA receptors primarily in the dorsal 
hippocampus.  Thus, memory for the trauma is not necessary to produce SEFL; the 
associative learning about the trauma can be blocked while the non-associative processes 
that lead to SEFL are left unchanged.  The findings reported here are similar to those 
reported by Rau, Fanselow, and Eger in (Sher & Vilens, 2010); when the SEFL test occurred 
after a five day period between the trauma/drug administration midazolam did not 
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diminish SEFL but did alter memory for the trauma.  Rau et al. used a 4 foot-shock 
procedure, which has previously been shown to produce SEFL almost as robustly as the 15 
foot-shock procedure (Rau, Oh, Laster, Eger, & Fanselow, 2009), and  although in the current 
experiments we used the more severe 15 foot-shock procedure, midazolam was still able to 
diminish the associative memory of the trauma.  The dose used in the present experiments 
was slightly higher than in the Rau et al. experiments (2 mg/kg vs. 1.5 mg/kg), however the 
15 shock procedure lasts 90 minutes while the 4 shock procedure lasts only 20 minutes.  It is 
possible that midazolam induced only partial amnesia for the trauma context (rather than 
the abolition of fear observed in the Rau et al., experiments) because of the length of the 
conditioning sessions; during the latter portion of the 15 shock procedure the midazolam 
could have been less effective, allowing contextual fear learning in the trauma context to 
occur.  
Limitations of propranolol 
It is possible that time of treatment may be a factor that determines the efficacy of 
propranolol.  Early studies using propranolol were especially exciting because it could be 
administered after the occurrence of trauma.  This is important given the unexpected nature 
of trauma, and rather than requiring prophylactic administration in case trauma occurs, 
propranolol could be given to victims of trauma following the event.  However, because we 
administered the drug both prior to and following the trauma we were able to take 
advantage of propranolol’s effect on general arousal (decreasing heart rate and blood 
pressure (Gerber et al., 1980)) as well as its reported post-trauma effects on emotional 
memory.  
The second difference among studies is the type of trauma: in the human literature, when 
propranolol was tested for efficacy after combat-related trauma, propranolol was ineffective 
(McGhee et al., 2009) while propranolol administered after car accidents or assault was 
found to be effective.  We speculate that the 15-shock trauma may have been more similar to 
the intensity of trauma produced by a combat situation, and that the severity of the trauma 
is possibly a factor in propranolol’s efficacy.  Propranolol may be effective in mitigating 
certain types of trauma while for other types the effect of propranolol may not be powerful 
enough to ameliorate the effects of severe trauma.  There is some evidence that propranolol 
may be an effective in altering fear memory during re-consolidation (Kindt et al., 2009).  
However, human laboratory fear learning procedures are far less severe than either 
exposure to real trauma in humans or foot-shock trauma in rodents.  The possibility remains 
that reconsolidation of learned fear might be altered by the physiological effects of the drug; 
memories of the trauma that are recalled under propranolol might produce less 
physiological arousal, decreasing emotional salience.  However, SEFL is unchanged by 
extinction as well as amnesia for the trauma (Rau et al., 2005) and along with our findings in 
Experiment 1 this suggests that manipulations focused on altering the associative 
component of SEFL may not be effective. 
A third possible difference among the outcomes of propranolol studies is the type of 
learning or memory that is being evaluated, and what symptoms or behaviors are being 
measured.  Emotional memory per se can be studied in rodents, by measuring freezing to 
assess fear learning and expression; however in human studies self-report measures or 
galvanic skin response are often employed.  Additionally, studies of emotional learning and 
memory often focus on associative symptoms directly related to the traumatic event; 
however, SEFL is a phenomenon that illustrates a non-associative processes and behavior 
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that is indicative of a sensitization of fear learning—most studies do not look at these 
processes.  These non-associative processes, however, are likely to be significant 
contributors to PTSD symptomology. 
Emotionally arousing stimuli may increase noradrenergic activity and thereby enhance 
memory (Cahill et al., 1994; Roozendaal, Okuda, de Quervain, & McGaugh, 2006), but this 
effect may be limited to milder emotionally arousing situations.  It is possible that in our 
findings we did not detect any diminution of enhanced memory in the propranolol group 
because of the strong emotional effect produced by the 15-shock trauma.  Perhaps if the 
trauma procedure was less emotionally arousing it might be possible to discern an effect of 
propranolol.  Reist et al. (2001) found that propranolol had the same effect of reducing recall 
for an emotionally arousing story in patients with PTSD as for control subjects, suggesting 
that propranolol might be effective at reducing memory for subsequent milder stressors that 
lead to behavioral phenomena like SEFL.  However, this suggests that propranolol would 
not be an effective treatment for the most severe aspects of PTSD, which are those most in 
need of treatment.  
Paradoxically, extreme arousal of the NE system causes memory deficits (Kobori, Hu, & 
Dash, 2010).  In this regard it is possible that propranolol was actually having a dulling 
effect on the trauma memory so that the lowered NE arousal allowed memory formation 
about the trauma when it might otherwise have been decreased.  However, given the data 
from the control groups, which show identical levels of trauma context fear, the animals 
without propranolol were able to learn and remember the trauma context as well as their 
propranolol counterparts.  
Limitations of allopregnanolone 
Allopregnanolone has been shown to produce behavioral changes in other paradigms such 
as in operant conditioning experiments looking at voluntary alcohol consumption.  
Behavioral effects at doses of allopregnanolone that were similar or even lower than the 
dose used in Experiment 3 have been observed (Janak & Gill, 2003; Janak et al., 1998); doses 
of 3 mg/kg and 5.6 mg/kg increased alcohol consumption, suggesting that the reinforcing 
properties of alcohol, exerting its effects at the GABAA receptors containing a4 subunits, was 
enhanced with the administration of allopregnanolone.  
There is evidence that tonic GABAergic inhibition via interneurons in the basolateral 
amygdala are responsible for modulation of excitatory projection neurons in this region 
(Ehrlich et al., 2009), and that GABAergic disinhibition produces increases in neural 
excitability and plasticity leading to pathological anxiety (Rainnie et al., 2004; Shekhar et al., 
2005). We had hypothesized that by elevating circulating levels of allopregnanolone before 
trauma that the neurosteroid might be able to enhance GABAergic response to the traumatic 
stress, thereby impeding over-activation of brain regions involved in fear learning and the 
consequent long-term effects of trauma.  A single acute administration of allopregnanolone, 
however, may not have a strong enough influence on the fear circuitry to counteract the 
effects of trauma.  SEFL is a long-lasting behavioral effect that has been observed as long as 
90 days after the initial trauma (Rau 2009).  Thus, the trauma seems to be permanently 
altering the fear learning circuit and it is likely that a transient boost in allopregnanolone 
was not able to mitigate the effects of trauma.   
Down-regulation the GABAA receptor a4 subunit gene as a consequence of SEFL 
(Ponomarev et al., 2010) led us to speculate that during stress allopregnanolone at the a4-
containing receptors might act as a protective mechanism. However, allopregnanolone did 
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not alter SEFL or fear memory for the trauma.  Since we did not measure direct changes in 
GABAA receptor a4 subunit expression after acute administration of allopregnanolone 
under conditions of traumatic stress and because SEFL behavior was unaffected, we can 
only speculate that down-regulated expression of the GABAA receptors was not affected by 
allopregnanolone.  Likewise, in the animals that received allopregnanolone on the day 
following the 15-shock trauma and before the single shock in the novel environment we saw 
no effect.  In this case it is possible that because changes in receptor expression can occur 
very rapidly, that down-regulation of the GABAA receptor a4 subunit had already occurred 
as a consequence of trauma, and furthermore that by the time the allopregnanolone was 
administered there were fewer receptor targets, especially in the amygdala, at which to exert 
an effect.  A final concern about the use of allopregnanolone is that allosteric modulators 
often act as feedback mechanisms in the brain.  Thus, a surplus of allopregnanolone might 
have interfered with endogenous feedback mechanisms, producing contradictory effects to 
those of endogenous allopregnanolone release. 
5. Conclusion 
Many of the pharmacological treatments for anxiety disorders such as PTSD focus on 
ameliorating symptoms that are specifically related to the fear learning and memory of the 
trauma.  These types of treatments, though they may be effective treatments for cognitive 
and declarative aspects of the disorder, do not affect symptoms like SEFL, which may be 
responsible for some of the treatment refractory symptoms of PTSD.   
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